This course type is lecture

Molecular Neurodegeneration

14 - 18 January 2019Wellcome Genome Campus, UK
Deadlines (at 23:59 UTC):
  • Application and bursary deadline Closed

Overview of the molecular basis of neurodegenerative disorders and introduction to bioinformatic approaches relevant to neurology

  • Summary

    This course provides an overview of the molecular basis of neurodegeneration and the development of therapeutic intervention to combat neurodegenerative disorders. The programme will cover several neurological disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. It will highlight experimental techniques used in neurogenetics and stem cell research. The course will provide an introduction to bioinformatic approaches relevant to neurology, including genome-wide association studies.

    Participants will gain an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies.

    The programme is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinical scientists, veterinary scientists, PhD students and post-doctoral researchers. We encourage applications from researchers based in the pharmaceutical and biotechnology industries. Applications from those who have completed a PhD in another area and have moved into neuroscience for their postdoctoral studies will also be considered.

    The course will benefit researchers who seek a comprehensive view of neurodegenerative disorders together with state of the art research techniques, and who wish to gain a new perspective on their own studies. The intensive programme provides the opportunity to interact with leading neuroscientists. To optimize discussions and interactions, numbers are limited to 30 students.

    Learning outcomes

    After attending this course, participants will be able to:

    • Describe in detail the process of neurodegeneration
    • Discuss and contrast different neurodegenerative disorders
    • Critique the impact and limitations on the use of big data in the field of neurodegeneration
    • Interpret and communicate the findings of genomics studies from single cells to large populations
    • Critically evaluate the advantages and disadvantages of varying disease models, from fly models to patient-derived iPSCs
    • Describe recent advances in therapeutic and translational areas to prevent and treat neurodegenerative diseases
    • Apply concepts learned on the course to your own research project
  • Programme

    The course will start at approximately 12.00 on Monday, 14 January and close at approximately 16.00 on Friday, 18 January 2019.

    The programme is lecture-based but highly interactive. Participants will have the opportunity to share their research with tutors, speakers and other students throughout the course, during the formal poster sessions and discussion sessions. Tutors are available throughout the course.

    Topics will include:

    • Clinical features of neurodegenerative disorders
    • Pathological events in varying neurodegenerative diseases
    • Cerebrovascular regulation in stroke
    • Modelling neurodegenerative diseases from flies to iPSCs
    • Bioinformatics and genome-wide association studies in neurodegenerative diseases
    • Stress pathways in neurodegeneration
    • Development of therapeutic approaches

     

    This is a residential course. All students are requested to stay onsite for the full duration to benefit fully from discussions and interactions with the faculty and other students.

     

  • Instructors and Speakers

    Scientific Committee

     Beverly Davidson

    Beverly Davidson
    Children’s Hospital of Philadelphia & The University of Pennsylvania, USA

    Rita Sattler

    Rita Sattler
    Barrow Neurological Institute, USA

    Nicholas Wood

    Nicholas Wood
    University College London, UK

    Confirmed tutors

    Nancy Bonini – University of Pennsylvania, USA
    Valina Dawson – Johns Hopkins University, USA
    Karen Duff  – Columbia University, USA
    Alexandra Durr – Pitie-Salpetriere University Hospital, France
    Costantino Iadecola –  Weill Cornell Medical College, USA
    Huw Morris – University College London, UK
    David Nelson – Baylor College of Medicine, USA
    Selina Wray – University College London, UK
    Yi Xing – Children’s Hospital of Philadelphia, USA

    Advanced Courses and Scientific Conferences Team

    Nicole Schatlowski, Scientific Programme Officer
    Lucy Criddle, Conference & Events Organiser

  • How to apply

    Fees

    Academic registration with accommodation £750
    Commercial registration with accommodation £1050

    The fees include accommodation, meals and lectures for the duration of the course. The fee will be requested once acceptance is confirmed.

    Accommodation
    This is a residential course. All participants will stay at The Wellcome Genome Campus Conference Centre, Hinxton, Cambridge, for the nights of 14, 15, 16 and 17 January 2019.
    If you wish to book onsite accommodation either side of the course dates, please contact the Conference Centre directly.

    Application deadline: 6 November 2018

    Places on this course are limited and will be awarded on merit. Applicants should be currently engaged in relevant research and will be required to complete an online application form. The selection process will take place in November 2018.

    The following will need to be provided:

    • Qualifications and justification for attendance
    • A list of relevant publications
    • An outline of current research
    • Supervisor’s details: your supervisor will then receive an e-mail requesting a supporting statement to complete your application.


    Please note:
    Applications cannot be considered without a supervisor’s supporting statement.

    Travel visas
    Please contact the event organiser if you require a letter to support a travel visa application. Note that letters will be provided to confirmed attendees.

    Non-European Economic Area or Swiss nationals may be required to have a visa to enter the UK. Early application is strongly advised, as this process can take 6-8 weeks or longer.

    Please visit the following websites for further information:

  • Bursaries

    A number of bursaries are available for dermatology trainees, PhD students and postdocs to attend this course.

    • Bursaries provided by the British Association of Dermatologists (BAD) will cover the full expense of the course
    • Bursaries provided by ACSC will cover up to 50% of the course fee

    Please indicate in your application for which scheme you would like to apply for.

    The following documents will need to be provided:

    • CV
    • A justification letter from applicant
    • A supporting letter from supervisor stating financial need

    To apply, please contact the event organiser.

    Bursary deadline: 4 September 2018

    Additional funding opportunities: Visit our Funding webpage for additional funding opportunities currently available.

    A number of bursaries are available for dermatology trainees, PhD students and postdocs to attend this course.

    Bursaries provided by the British Association of Dermatologists (BAD) will cover the full expense of the course
    Bursaries provided by ACSC will cover up to 50% of the course fee

    Please indicate in your application for which scheme you would like to apply for.

    The following documents will need to be provided:

    CV
    A justification letter from applicant
    A supporting letter from supervisor stating financial need

    To apply, please contact the event organiser.

    Bursary deadline: 4 September 2018

    Additional funding opportunities: Visit our Funding webpage for additional funding opportunities currently available.

    A number of bursaries are available for dermatology trainees, PhD students and postdocs to attend this course.

    Bursaries provided by the British Association of Dermatologists (BAD) will cover the full expense of the course
    Bursaries provided by ACSC will cover up to 50% of the course fee

    Please indicate in your application for which scheme you would like to apply for.

    The following documents will need to be provided:

    CV
    A justification letter from applicant
    A supporting letter from supervisor stating financial need

    To apply, please contact the event organiser.

    Bursary deadline: 4 September 2018

    Additional funding opportunities: Visit our Funding webpage for additional funding opportunities currently available.

    sdfsdf

    A limited number of registration bursaries are available for PhD students to attend this course (up to 50% of the standard fee).

    The following documents will need to be provided:

    •     CV
    •     Covering letter
    •     Letter from supervisor

    To apply, please contact the event organiser.

    Bursary deadline: 6 November 2018

    Additional funding opportunities: Visit our Funding webpage for additional funding opportunities currently available.

     

  • Testimonials

    Feedback from previous courses:

    ‘The best part of the course was the quality of the invited speakers. I also found the poster sessions a very useful way to meet the other attendees and learn about their research.’

    ‘Thank you for providing such a welcoming and friendly environment. This was an intense course but the organisers made it feel more relaxed and enjoyable while highly educational.’

    ‘Great course, really enjoyed the variety of backgrounds from the participants and the friendliness and approachability of the lecturers.’

    ‘This is the best course I have been on. The interactive element to the course with fantastic speakers and a small group of participants is truly unique. The speakers and topics chosen perfectly complemented each other. By the end of the course key mechanisms and therapeutic strategies across the breadth of the neurodegenerative diseases were highlighted with important common themes emerging across diseases. I came away with lots of ideas to take to the lab.’